MedTrace Logo

Efficacy of tDCS in the Treatment of Resistant Auditory Hallucinations in Schizophrenia

NCT04352569 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2024-02-16

No results posted yet for this study

Summary

The regions which are assumed to underlie the pathophysiology of schizophrenia, namely hypoactivity at the prefrontal level and pathological hyperactivity of the associative regions of the language located in the left temporoparietal region.

To assess the efficacy of tDCS on auditory hallucinations, the investigators performs an randomized double blind versus placebo trial. In each arms patients will receive two tDCS sessions a day during two weeks.

Conditions

Interventions

DEVICE

transcranial direct current stimulation

transcranial direct current stimulation (tDCS) is a non invasive brain stimulation technic

Sponsors & Collaborators

  • Centre hospitalier de Ville-Evrard, France

    lead OTHER

Principal Investigators

  • NOOMANE BOUAZIZ, MD · Unité de Recherche Clinique de l'EPS de Ville Evard

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-03
Primary Completion
2023-12-08
Completion
2026-03-10

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04352569 on ClinicalTrials.gov